Mizuho Securities Initiates Coverage On Sabra Health Care REIT with Neutral Rating, Announces $22 Price Target

Mizuho Securities analyst Omotayo Okusanya initiates coverage on Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral rating and a $22 price target.

Benzinga · 12/20/2019 11:51

Mizuho Securities analyst Omotayo Okusanya initiates coverage on Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral rating and a $22 price target.